BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Continente #
NA - Nord America 9.381
EU - Europa 6.943
AS - Asia 2.270
AF - Africa 270
SA - Sud America 170
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 19.061
Nazione #
US - Stati Uniti d'America 9.236
RU - Federazione Russa 3.388
DE - Germania 1.509
SG - Singapore 903
CN - Cina 810
UA - Ucraina 609
GB - Regno Unito 352
SE - Svezia 286
IT - Italia 252
CM - Camerun 236
VN - Vietnam 190
FR - Francia 172
FI - Finlandia 140
CA - Canada 122
BR - Brasile 120
IE - Irlanda 96
KR - Corea 94
PL - Polonia 94
TR - Turchia 90
HK - Hong Kong 44
IN - India 44
EU - Europa 22
MX - Messico 16
EC - Ecuador 14
BD - Bangladesh 11
ZA - Sudafrica 11
ES - Italia 10
ID - Indonesia 10
IL - Israele 10
AR - Argentina 9
JP - Giappone 8
MA - Marocco 8
PE - Perù 8
SA - Arabia Saudita 8
CO - Colombia 6
IQ - Iraq 5
IR - Iran 5
NL - Olanda 5
PK - Pakistan 5
BE - Belgio 4
HU - Ungheria 4
KE - Kenya 4
MY - Malesia 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
AZ - Azerbaigian 3
GR - Grecia 3
JO - Giordania 3
LT - Lituania 3
PH - Filippine 3
TH - Thailandia 3
AM - Armenia 2
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
KZ - Kazakistan 2
MN - Mongolia 2
NP - Nepal 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GP - Guadalupe 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
KI - Kiribati 1
KY - Cayman, isole 1
LY - Libia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 19.061
Città #
Fairfield 1.564
Ashburn 1.049
Woodbridge 699
Seattle 696
Beijing 665
Houston 661
Cambridge 604
Jacksonville 560
Chandler 539
Wilmington 504
San Jose 368
Singapore 325
Moscow 305
Ann Arbor 213
Dallas 187
London 146
The Dalles 110
Ottawa 106
Boardman 103
Chicago 96
Dublin 93
Naples 93
Seoul 93
Lawrence 90
Princeton 86
New York 79
Helsinki 70
Ho Chi Minh City 67
Kraków 65
Rome 64
San Diego 49
Los Angeles 43
Hanoi 41
Hong Kong 41
Frankfurt am Main 39
Saint Petersburg 35
Portsmouth 28
Yubileyny 25
Warsaw 21
Lauterbourg 19
Nanjing 17
Milan 16
Norwalk 16
Prescot 16
Mumbai 14
San Francisco 14
Cedar Knolls 13
Council Bluffs 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Mexico City 12
Da Nang 11
Hillsboro 11
Orem 11
Santa Clara 11
Düsseldorf 10
Haiphong 9
Hefei 9
Islington 9
Kilburn 9
Roubaix 9
São Paulo 9
Atlanta 8
Chennai 8
Dearborn 8
Hounslow 8
Johannesburg 8
Falls Church 7
Mcallen 7
Tokyo 7
Wroclaw 7
St Petersburg 6
Boston 5
Brooklyn 5
Chengdu 5
Guayaquil 5
Nanchang 5
Quito 5
Redmond 5
St Louis 5
Stockholm 5
Bexley 4
Biên Hòa 4
Brussels 4
City of London 4
Guarulhos 4
Istanbul 4
Nairobi 4
New Bedfont 4
Paris 4
Phú Thọ 4
Reston 4
Rio de Janeiro 4
Shanghai 4
Toronto 4
West Jordan 4
Amsterdam 3
Ankara 3
Totale 11.115
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 599
Immune and metabolic alterations in first episode psychosis (FEP) patients 397
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 341
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 329
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 302
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 296
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 292
Allelic variation in the human prodynorphin gene promoter and schizophrenia 282
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 271
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 268
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 267
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 265
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 265
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 261
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 261
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 257
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 254
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 253
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 251
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 250
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 249
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 247
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 244
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 243
Glucose metabolism alterations in patients with bipolar disorder 242
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 242
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 239
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 239
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 237
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 236
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 235
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 235
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 234
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 232
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 230
Blood microRNA changes in depressed patients during antidepressant treatment 230
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 230
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 230
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 229
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 229
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 226
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 224
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 223
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 215
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 214
Season of birth and inflammatory response system in schizophrenia 214
Markers of Alzheimer's disease in a population attending a memory clinic 213
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 212
VEGF serum levels in depressed patients during SSRI antidepressant treatment 212
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 211
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 209
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 208
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 206
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 205
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 204
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 201
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 199
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 198
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 191
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 190
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 184
Childhood trauma and glucose metabolism in patients with first-episode psychosis 180
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 174
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 167
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 167
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 166
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 164
Gene-environment interaction in major depression: focus on experience-dependent biological systems 163
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 156
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 156
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 154
The cytokine network genes and resistance to antipsychotics in schizophrenia 151
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 151
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 150
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 150
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 146
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 144
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 142
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 140
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 139
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 136
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 133
Molecular mechanisms of brain stimulation. (Chapter 11). 122
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 102
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 96
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 94
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 87
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 82
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 72
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 70
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 70
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 61
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics" 43
Exploration of Early-Treatment-Associated Changes in Metabolic and Inflammatory Biomarkers in First-Episode Psychosis in Italian Patients 18
The Oral–Brain Axis in Alzheimer’s Disease: From Microbial Dysbiosis to Neurodegeneration 15
null 5
null 2
null 1
null 1
null 1
Totale 19.223
Categoria #
all - tutte 95.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021430 0 0 0 0 0 0 0 0 0 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20254.245 34 22 18 3 113 319 2.282 779 302 62 183 128
2025/20262.397 181 102 371 286 168 84 439 304 372 90 0 0
Totale 19.223